Exercise Price Adjustment for 5th Series BW from 4,043 KRW to 2,831 KRW, Potential Dilution of 16% Raises Concerns for Existing Shareholders
Due to market price decline, the exercise price of the 5th series bonds with warrants was adjusted downward by 30% from 4,043 KRW to 2,831 KRW.
The number of exercisable shares increased from approximately 2.73 million to 3.89 million, representing a potential dilution of about 16% of outstanding shares.
This adjustment is automatic per the bond terms without a separate board resolution.
[AI Summary]The downward adjustment of the warrant exercise price substantially increases potential equity dilution, threatening existing shareholder value and likely exerting downward pressure on the stock price.
KOSDAQ Filing Information
Adjustment of Exercise Price of Stock Subscription Rights
Company: Green Cross Medical Science (142280)
Submission: Green Cross Medical Science Corporation